Literature DB >> 10381480

Risk of post-discharge venous thromboembolism in patients with rheumatoid arthritis undergoing knee or hip arthroplasty. Is prolonged thromboprophylaxis warranted or dangerous?

M T Nurmohamed1, W F Lems, B A Dijkmans.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10381480      PMCID： PMC1752914          DOI： 10.1136/ard.58.7.392

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  28 in total

Review 1.  The postdischarge risk of venous thromboembolism after hip replacement. The role of prolonged prophylaxis.

Authors:  D Bergqvist
Journal:  Drugs       Date:  1996       Impact factor: 9.546

2.  Major orthopaedic surgery and post-discharge DVT.

Authors:  J W ten Cate; M H Prins
Journal:  Lancet       Date:  1996-07-27       Impact factor: 79.321

3.  Prolonged thromboprophylaxis following hip replacement surgery--results of a double-blind, prospective, randomised, placebo-controlled study with dalteparin (Fragmin)

Authors:  O E Dahl; G Andreassen; T Aspelin; C Müller; P Mathiesen; S Nyhus; M Abdelnoor; J H Solhaug; H Arnesen
Journal:  Thromb Haemost       Date:  1997-01       Impact factor: 5.249

Review 4.  Low molecular weight heparins: prophylaxis of venous thromboembolism in surgical patients.

Authors:  V V Kakkar
Journal:  Semin Hematol       Date:  1997-10       Impact factor: 3.851

Review 5.  Antiplatelet treatment for thromboprophylaxis: a step forward or backwards?

Authors:  A T Cohen; J A Skinner; V V Kakkar
Journal:  BMJ       Date:  1994-11-05

6.  Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement.

Authors:  D Bergqvist; G Benoni; O Björgell; H Fredin; U Hedlundh; S Nicolas; P Nilsson; G Nylander
Journal:  N Engl J Med       Date:  1996-09-05       Impact factor: 91.245

7.  Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy.

Authors:  G Palareti; N Leali; S Coccheri; M Poggi; C Manotti; A D'Angelo; V Pengo; N Erba; M Moia; N Ciavarella; G Devoto; M Berrettini; S Musolesi
Journal:  Lancet       Date:  1996-08-17       Impact factor: 79.321

Review 8.  Low molecular weight heparin(oid)s. Clinical investigations and practical recommendations.

Authors:  M T Nurmohamed; H ten Cate; J W ten Cate
Journal:  Drugs       Date:  1997-05       Impact factor: 9.546

9.  Risk of deep-venous thrombosis after hospital discharge in patients having undergone total hip replacement: double-blind randomised comparison of enoxaparin versus placebo.

Authors:  A Planes; N Vochelle; J Y Darmon; M Fagola; M Bellaud; Y Huet
Journal:  Lancet       Date:  1996-07-27       Impact factor: 79.321

10.  Effect of the low molecular weight heparin/non steroidal anti-inflammatory drugs association on an experimental thrombosis induced by laser.

Authors:  F Doutremepuich; O Aguejouf; P Imbault; F A Oualane; C Doutremepuich
Journal:  Thromb Res       Date:  1995-02-15       Impact factor: 3.944
View more
  2 in total

1.  Prevention of post-discharge venous thromboembolism in patients with rheumatoid arthritis undergoing knee or hip arthroplasty: a continuing matter of debate.

Authors:  M T Nurmohamed; B A Dijkmans; B A Dijkmans
Journal:  Ann Rheum Dis       Date:  2001-10       Impact factor: 19.103

2.  [Postoperative management of hip and knee endoprostheses].

Authors:  S Seitz; W Rüther
Journal:  Z Rheumatol       Date:  2012-10       Impact factor: 1.372
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.